Genetic microheterogeneity of human transthyretin detected by IEF

被引:28
作者
Altland, Klaus
Benson, Merrill D.
Costello, Catherine E.
Ferlini, Alessandra
Hazenberg, Bouke R. C.
Hund, Ernst
Kristen, Arnt V.
Linke, Reinhold P.
Merlini, Giampaolo
Salvi, Fabrizio
Saraiva, Maria J.
Singer, Reinhard
Skinner, Martha
Winter, Pia
机构
[1] Univ Giessen, Inst Human Genet, D-35392 Giessen, Germany
[2] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA
[3] Boston Univ, Sch Med, Mass Spectrometry Resource, Boston, MA 02118 USA
[4] Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol, Groningen, Netherlands
[6] Neurolog Univ Klin, Heidelberg, Germany
[7] Med Univ Klin, Heidelberg, Germany
[8] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[9] Univ Hosp, Policlin San Matteo, Dept Biochem, Pavia, Italy
[10] Dipartimento Neurosci, Bologna, Italy
[11] Univ Porto, Inst Mol & Cellular Biol, P-4100 Oporto, Portugal
[12] Chirurg Univ Klin, Heidelberg, Germany
[13] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02215 USA
关键词
amyloidosis; familial amyloiclotic polyneuropathy; microheterogeneity; transthyretin; urea titration curve;
D O I
10.1002/elps.200600840
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Mutations of the human transthyretin (TTR) gene have attracted medical interest as a cause of amyloidosis. Recently, we have described in detail an electrophoretic procedure with PAGE followed by IEF in urea gradients for the study of the microheterogeneity of TTR monomers (Altland, K., Winter, P., Sauerborn, M. K., Electrophoresis 1999, 20,1349-1364). in this paper, we present a study on 49 different mutations of TTR including 33 that result in electrically neutral amino acid substitutions. The aims of the investigation were to test the sensitivity of the procedure to detect TTR variants in patients with TTR amyloidosis and their relatives and to identify some common characteristics that could explain the amyloidogenicity of these variants. We found that all tested amyloidogenic mutations could be detected by our method with the exception of those for which the corresponding variant was absent in plasma samples. Most of the electrically neutral amyloidogenic TTR variants had in common a reduced conformational. stability of monomers by the activity of protons and urea. For three variants, e.g. TTR-F64L, TTR-1107V and TTR-V122I, the monomers had a conformational stability close to that of normal monomers but we found experimental and structural arguments for a weakening of the monomer-monomer contact. All types of amyloidogenic mutations affected the stability of TTR tetramers.
引用
收藏
页码:2053 / 2064
页数:12
相关论文
共 39 条
[1]
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis [J].
Adamski-Werner, SL ;
Palaninathan, SK ;
Sacchettini, JC ;
Kelly, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (02) :355-374
[2]
Altland K, 1999, ELECTROPHORESIS, V20, P1349, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1349::AID-ELPS1349>3.0.CO
[3]
2-5
[4]
Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin [J].
Altland, K ;
Winter, P ;
Saraiva, MJM ;
Suhr, O .
NEUROGENETICS, 2004, 5 (01) :61-67
[5]
FORMING REPRODUCIBLE DENSITY AND SOLUTE GRADIENTS BY COMPUTER-CONTROLLED COOPERATION OF STEPMOTOR-DRIVEN BURETS [J].
ALTLAND, K ;
ALTLAND, A .
ELECTROPHORESIS, 1984, 5 (03) :143-147
[6]
Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin [J].
Altland, K ;
Winter, P .
ELECTROPHORESIS, 2003, 24 (14) :2265-2271
[7]
Potential treatment of transthyretin-type amyloidoses by sulfite [J].
Altland, K ;
Winter, P .
NEUROGENETICS, 1999, 2 (03) :183-188
[8]
ALTLAND K, 1996, NEUROMUSCULAR DISORD, V6, pS17
[9]
Alves IL, 1997, HUM MUTAT, V9, P226, DOI 10.1002/(SICI)1098-1004(1997)9:3<226::AID-HUMU3>3.3.CO
[10]
2-W